Blast phase of essential thrombocythemia: A single center study-Reference-Cited by-同舟云学术

Blast phase of essential thrombocythemia: A single center study

Published:2009-10 Issue:10 Volume:84 Page:641-644
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Passamonti Francesco,Rumi Elisa,Arcaini Luca,Elena Chiara,Castagnola Carlo,Zappasodi Patrizia,Bernasconi Paolo,Pietra Daniela,Pascutto Cristiana,Cazzola Mario,Lazzarino Mario

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.21496/fullpdf

Reference42 articles.

1. Proposals and rationale for revision of the world health organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel;Tefferi;Blood,2007

2. A gain-of-function mutation of JAK2 in myeloproliferative disorders;Kralovics;N Engl J Med,2005

3. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders;Pietra;Blood,2008

4. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia;Pikman;PLoS Med,2006

5. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis;Tefferi;Leukemia,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction of Anemia and Evaluation of Efficacy of Red Blood Cell Transfusion in Patients with Oncohematological Diseases;Clinical oncohematology;2018

2. Prognostication in myelofibrosis;Novel Insights into Myelofibrosis Pathophysiology and Treatment;2015-05

3. Leukemic transformation in essential thrombocythemia;Future Oncology;2014-12

4. Clinical Predictors of Outcome in MPN;Hematology/Oncology Clinics of North America;2012-10

5. New generation small-molecule inhibitors in myeloproliferative neoplasms;Current Opinion in Hematology;2012-03